MDGL 308.44 (+5.12%)
US5588681057BiotechnologyBiotechnology

Madrigal Pharmaceuticals (MDGL) Financial Metrics

This table shows a selected set of financial data points of Madrigal Pharmaceuticals (MDGL). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -19.99 0 -11.57 4.32B -0.74 0 -325.71M -360.39M -373.63M 99.92M
2022 -17.23 0 -16.84 4.97B -0.93 0 -225.07M -290.92M -295.35M 331.55M
2021 -14.63 0 -5.79 1.4B -0.86 37.32K -184.13M -241.44M -241.85M 36.27M
2020 -13.09 0 -8.49 1.72B -0.55 21.86K -157.9M -206.2M -202.24M 54M
2019 -5.45 0 -16.71 1.4B -0.18 0 -41.8M -94.97M -83.95M 46.7M
2018 -2.22 0 -50.83 1.67B -0.1 200K -25.53M -32.72M -32.81M 57.38M
2017 -2.54 0 -36.08 1.12B -0.27 350K -22.44M -31.08M -31.15M 148.63M
2016 -5.07 0 -2.94 77.55M -0.48 0 -17.61M -25.18M -26.39M 19.14M
2015 -18.69 0 -0.66 45.01M -0.81 0 -71.5M -66.95M -68.67M 34.97M
2014 -30.62 0 -3.03 260.99M -0.88 0 -79.07M -83.28M -86.16M 46.02M
2013 -44.48 0 -4.12 371.91M -0.91 0 -78.18M -87.04M -90.19M 48.49M
2012 -36.99 0 -8.53 535.88M -0.86 147K -54.64M -60.2M -62.79M 81.51M
2011 -35.14 0 -4.65 220.41M -0.98 7.58M -47.99M -43.97M -47.38M 30.08M
2010 -32.49 0 -6.59 247.03M -0.73 14.8M -38.34M -34.97M -37.47M 31.31M
2009 81.13 0 2.18 172.64M 1.08 144.25M -27.26M 81.86M 79.09M 44.16M
2008 -96.09 0 -2.23 206.46M -0.84 2.62M -40.12M -89.9M -92.62M 52.05M
2007 -68.45 0 -3.43 217.52M -0.72 743K 24.87M -60.14M -63.5M 115.58M
2006 -90.03 0 0 0 -0.91 0 -54.57M -53.62M -57.27M 33.69M
2005 -108.31 0 0 0 -0.68 0 -66.77M -66.41M -68.86M 23.81M
2004 -59.09 0 0 0 -0.43 173K -35.39M -44.39M -45.93M 42.74M
2003 -44.65 0 0 0 -0.69 1.3M -24.38M -26.87M -27.88M 36.06M
2002 -105.09 0 0 0 -26.08 0 0 -36.15M -36.15M 0
2001 -4.55 0 0 0 0 0 0 -381K -381K 0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.